Renew the paradigm. Optimize our therapy.
This week, a thyroid patient from British Columbia posted an image of a piece of paper handed to her at a LifeLabs laboratory. LifeLabs BC was using this paper leaflet to explain to her why "Free T3 and Free T4 will not be tested when the TSH is in reference range." THE LEAFLET GIVEN TO …
Continue reading LifeLabs BC handout reveals thyroid testing policy failure
This post engages in a moral argument, not a scientific one. Thyroid pharmaceutical prejudice is part of a paradigm that is refusing to shift. We need to keep asking key questions and fight together for this shift. Look around you today. Thyroid guidelines and health care systems currently treat all thyroid patients as one undifferentiated …
Continue reading Pharma prejudice refuses a paradigm shift in thyroid therapy
By Tania S. Smith. Updated May 8, 2019 "Thyroid pharmaceutical prejudice" is simply a bias against one thyroid hormone pharmaceutical type in favor of another. Prejudice claims that a particular thyroid medication is intrinsically unsafe or ineffective, for all patients under almost all circumstances. It's a type of "sweeping generalization" fallacy. The main aim of …
Continue reading Thyroid pharmaceutical prejudice: How it works
One of Canada's best thyroid doctors, Dr. Ron Matsusaki in Nova Scotia, has had his license to prescribe and treat thyroid suspended. His thyroid clinic in Digby has been under review for the past month, and the decision was announced on the clinic's Facebook group April 17, 2019.(1) Let's do everything we can to speak …
Continue reading Dr. Ron Matsusaki’s license to treat thyroid suspended April 17, 2019
On April 8, 2018 The Canadian Society for Endocrinology and Metabolism (CSEM) made the happy announcement that they have made an edit to their prohibition of FT3 and FT4 testing in hypothyroidism. At first, patients were elated, hopeful, feeling like they were finally being heard! Maybe the Canadian Thyroid Foundation said something to open the …
Continue reading CSEM’s edit to FT3 and FT4 testing prohibitions, April 8, 2019
Hypo, hyper, or well-medicated, millions of Canadians are in the category of those who manage a thyroid hormone imbalance. But instead of being offered the agency to co-manage our condition, we are being managed and manipulated by our medical system and economy. We thyroid patients are a huge amorphous group, way too easy and vulnerable …
Who is really sleeping a lot, and yet sleeping poorly? Sure, the hypothyroid patient. But someone else is sleeping too. Our Canadian medical system and the majority of our doctors who dismiss treated patients' symptoms and thyroid-related disorders whenever TSH is normal. Sleeping at the wheel. Where are we headed? Why are you nickel and …
